TAFRO syndrome complicating Sjogren's disease: response to subcutaneous tocilizumab. Uribe-Ruiz NA, Murillo-Baquero N, Vargas-Camacho AF, Santiago-Pacheco V, et al. Clin Rheumatol 2026;45:4667-4673.

Read + Share

Amedeo Smart

Independent Medical Education

Uribe-Ruiz NA, Murillo-Baquero N, Vargas-Camacho AF, Santiago-Pacheco V, et al. TAFRO syndrome complicating Sjogren's disease: response to subcutaneous tocilizumab. Clin Rheumatol 2026;45:4667-4673.
PMID: 42174299